DEFA1 and urinary bladder carcinoma: The plasma levels of DEFA1-3 in patients with bladder cancer are parallel to the progression and pathological stage of malignant tumor, suggesting that DEFA1–3 can promote bladder cancer invasion and could be potential indicators of disease progression (8).